Keeping the memory of smallpox virus
- PMID: 16964577
- PMCID: PMC11136027
- DOI: 10.1007/s00018-006-6313-2
Keeping the memory of smallpox virus
Abstract
Smallpox virus eradication was one of the greatest successes of the 20th century. Moreover, the quest to combat its use in biological warfare, has fueled efforts to understand residual immune memory and to develop new animal models by the scientific community. Although the literature is full of animal studies of vaccinia virus infection, continuing efforts have helped to increase our knowledge regarding humoral and cellular memory to non-persistent pathogens and to study factors that might influence further vaccination strategies in humans. In addition, the potent immunostimulatory action of poxvirus vectors has led to development and evaluation of new-generation vaccine candidates, which will be discussed in this review.
Similar articles
-
Bioterrorism. Smallpox vaccinations: how much protection remains?Science. 2001 Nov 2;294(5544):985. doi: 10.1126/science.294.5544.985. Science. 2001. PMID: 11691969 No abstract available.
-
The immunology of smallpox vaccines.Curr Opin Immunol. 2009 Jun;21(3):314-20. doi: 10.1016/j.coi.2009.04.004. Epub 2009 Jun 11. Curr Opin Immunol. 2009. PMID: 19524427 Free PMC article. Review.
-
Smallpox vaccines: targets of protective immunity.Immunol Rev. 2011 Jan;239(1):8-26. doi: 10.1111/j.1600-065X.2010.00975.x. Immunol Rev. 2011. PMID: 21198662 Free PMC article. Review.
-
[Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].Bull Acad Natl Med. 2006 Apr-May;190(4-5):1035-46; discussion 1046-9. Bull Acad Natl Med. 2006. PMID: 17195626 French.
-
Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.J Virol. 2004 Jul;78(13):7052-60. doi: 10.1128/JVI.78.13.7052-7060.2004. J Virol. 2004. PMID: 15194781 Free PMC article.
Cited by
-
Original encounter with antigen determines antigen-presenting cell imprinting of the quality of the immune response in mice.PLoS One. 2009 Dec 7;4(12):e8159. doi: 10.1371/journal.pone.0008159. PLoS One. 2009. PMID: 19997562 Free PMC article.
-
Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans.J Clin Invest. 2010 May;120(5):1636-44. doi: 10.1172/JCI38506. Epub 2010 Apr 1. J Clin Invest. 2010. PMID: 20364089 Free PMC article.
-
Viral gene therapy.Clin Transl Oncol. 2006 Dec;8(12):858-67. doi: 10.1007/s12094-006-0149-y. Clin Transl Oncol. 2006. PMID: 17169759 Review.
-
A novel high-throughput vaccinia virus neutralization assay and preexisting immunity in populations from different geographic regions in China.PLoS One. 2012;7(3):e33392. doi: 10.1371/journal.pone.0033392. Epub 2012 Mar 16. PLoS One. 2012. PMID: 22438922 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical